KALA BIO, Inc.
KALA
Kedudukan dalam Saham
#30854
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Harga Saham
$0.75
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$14.50M
Perubahan (1 hari)
2.78%
Perubahan (1 tahun)
-98.84%
Negara
US
Perdagangan KALA BIO, Inc. (KALA)
Kategori
Healthcare
Modal pasaran bagi KALA BIO, Inc.(KALA)
Modal Pasaran: $14.50M
Sehingga October 2026, KALA BIO, Inc. mempunyai modal pasaran sebanyak $14.50M. Ini menjadikan KALA BIO, Inc. syarikat ke-30854th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran KALA BIO, Inc. dari 2018 hingga 2026
KALA berbanding dengan 5 teratas yang paling popular stocks
| Harga KALA | Aset B | Pasaran B | Hasilnya | |
|---|---|---|---|---|
$37,404,068
$27.28K
|
$5.252T | +19,250,678,097.98% | ||
|
$35,616,068
$27.28K
|
$5.001T | +18,330,451,937.99% | ||
|
$29,740,041
$27.28K
|
$4.176T | +15,306,248,434.53% | ||
|
$28,258,146
$27.28K
|
$3.968T | +14,543,564,605.88% | ||
|
$20,204,130
$27.28K
|
$2.837T | +10,398,419,747.03% |
